Related references
Note: Only part of the references are listed.Metalloproteinase-1, metalloproteinase-7, and p53 immunoexpression and their correlation with clinicopathological prognostic factors in colorectal adenocarcinoma
Benicio L.B.B.P. Nunes et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS (2017)
The dimensions of the CRC problem
L. V. Karsa et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2010)
Global Patterns of Cancer Incidence and Mortality Rates and Trends
Ahmedin Jemal et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Cancer incidence and mortality in Iran
S. M. Mousavi et al.
ANNALS OF ONCOLOGY (2009)
A Comparison of Colon and Rectal Somatic DNA Alterations
Martha L. Slattery et al.
DISEASES OF THE COLON & RECTUM (2009)
Oesophageal and gastric intestinal-type adenocarcinomas show the same male predominance due to a 17 year delayed development in females
M. H. Derakhshan et al.
GUT (2009)
Epidemiology of colorectal cancer in Asia
Yuk Kei Yee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.
Sanford D. Markowitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Overview of Colorectal Cancer Genetics
Robert Gryfe
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2009)
hTERT expression in colorectal adenocarcinoma: correlations with p21, p53 expressions and clinicopathological features
Alfred King-Yin Lam et al.
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2008)
P53 mutations in colorectal cancer from Northern Iran:: Relationships with site of tumor origin, microsatellite instability and K-ras mutations
Mahboobeh Mahdavinia et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2008)
Prognostic significance of cyclooxygenase-2 expression and nuclear p53 accumulation in patients with colorectal cancer
Sung-Chul Lim et al.
JOURNAL OF SURGICAL ONCOLOGY (2008)
Mutations in TP53 are a prognostic factor in colorectal hepatic metastases undergoing surgical resection
David G. Mollevi et al.
CARCINOGENESIS (2007)
Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use
M. J. Duffy et al.
EUROPEAN JOURNAL OF CANCER (2007)
Relationship between genetic alterations and prognosis in sporadic colorectal cancer
SC Chang et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
The P53 pathway: what questions remain to be explored?
A. J. Levine et al.
CELL DEATH AND DIFFERENTIATION (2006)
The TP53 Colorectal Cancer International Collaborative Study on the prognostic and predictive significance of p53 mutation:: Influence of tumor site, type of mutation, and adjuvant treatment
A Russo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Systematic review of genetic influences on the prognosis of colorectal cancer
S Anwar et al.
BRITISH JOURNAL OF SURGERY (2004)
Co-mutation of p53, K-ras genes and accumulation of p53 protein and its correlation to clinicopathological features in rectal cancer
Zhi-Zhong Pan et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2004)
Cancer occurrence in Ardabil: Results of a population-based cancer registry from Iran
A Sadjadi et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis
S Kato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
V Bazan et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Apoptosis and chemoresistance in transgenic cancer models
CA Schmitt et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2002)
Regulation and function of the p53 tumor suppressor protein
KM Ryan et al.
CURRENT OPINION IN CELL BIOLOGY (2001)
NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription
JY Zhao et al.
GENES & DEVELOPMENT (2000)
Share Paper
